Related Experiment Video
Updated: May 31, 2026

09:15
Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Renal tumors in solid organ recipients: clinical and pathologic features
Matvey Tsivian1, Jorge R Caso, Masaki Kimura
1Department of Surgery, Duke University Medical Center, Durham, CT 27710, USA. matvey.tsivian@duke.edu
Urologic Oncology
|July 2, 2011
Summary
Solid organ transplant recipients have a higher risk of renal cell carcinoma (RCC). These tumors are often smaller and detected incidentally, but are more frequently malignant and of lower stage/grade, leading to good outcomes.
Area of Science:
- Urology
- Nephrology
- Oncology
Background:
- Solid organ recipients face a significantly increased risk of developing renal cell carcinoma (RCC) compared to the general population.
- Limited data exists on the specific characteristics of RCC in this vulnerable patient group.
Purpose of the Study:
- To characterize renal tumors in solid organ recipients.
- To compare these tumor features with those found in the general population.
Main Methods:
- Retrospective study of patients undergoing surgery for localized renal masses (2000-2008).
- Comparison of demographic, clinical, radiographic, and pathologic data between organ recipients and non-recipients.
- Subanalysis comparing kidney transplant recipients with other solid organ transplant recipients.
Main Results:
- Organ recipients (19/950) were younger, had lower BMI, and were often asymptomatic.
- RCC in recipients showed higher malignancy rates (88.2% vs. 78.7%), smaller size, lower stage/grade, and increased papillary histology (35.3% vs. 19.8%).
- Kidney recipients had nearly 50% papillary RCC, versus 20% in other organ recipients; excellent oncologic outcomes observed with no metastases or RCC deaths.
Conclusions:
- Renal masses in organ recipients are typically incidental, smaller, and more often malignant than in the general population.
- Despite higher malignancy rates, RCC in transplant recipients present at lower stages and grades.
- Surgical management of RCC in organ recipients appears to yield excellent oncologic outcomes.
Related Concept Videos
Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
